Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways

Endocrinology

Volumn 152, Issue 12, 2011, Pages 4571-4580

  Karagiannides, Iordanes ^a,e   Bakirtzi, Kyriaki ^a   Kokkotou, Efi ^b   Stavrakis, Dimitris ^a   Margolis, Kara Gross ^c   Thomou, Thomas ^b   Giorgadze, Nino ^d   Kirkland, James L ^d   Pothoulakis, Charalabos ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^d MAYO CLINIC   (United States)

^e South MRL Building 1240 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; PROTEIN KINASE C THETA; STRESS ACTIVATED PROTEIN KINASE; SUBSTANCE P; TACHYKININ 1; TACHYKININ DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DIABETES MELLITUS; ENZYME ACTIVATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC REGULATION; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ADIPOCYTES; ANIMALS; DIETARY FATS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MICE, KNOCKOUT; RECEPTORS, NEUROKININ-1; SIGNAL TRANSDUCTION; SUBSTANCE P; TACHYKININS; WEIGHT GAIN;

EID: 82355188234     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1170     Document Type: Article

References (49)

1. Kershaw EE, Flier JS 2004 Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89:2548-2556 (Pubitemid 38766330)
2. Ahima RS 2006 Adipose tissue as an endocrine organ. Obesity (Silver Spring) 14(Suppl 5):242S-249S
3. Karagiannides I, Pothoulakis C 2009 Substance P, obesity, and gut inflammation. Curr Opin Endocrinol Diabetes Obes 16:47-52
4. Jornayvaz FR, Samuel VT, Shulman GI 2010 The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome. Annu Rev Nutr 30:273-290
5. Dirat B, Bochet L, Escourrou G, Valet P, Muller C 2010 Unraveling the obesity and breast cancer links: a role for cancer-associated adipocytes? Endocr Dev 19:45-52
6. Hotamisligil GS 2008 Inflammation and endoplasmic reticulum stress in obesity and diabetes. Int J Obes (Lond) 32(Suppl 7):S52-S54
7. Hotamisligil GS 2010 Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900-917
8. Marra F, Bertolani C 2009 Adipokines in liver diseases. Hepatology 50:957-969
9. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867 (Pubitemid 46024993)
10. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science 271:665-668 (Pubitemid 26052915)
11. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS 2002 A central role for JNK in obesity and insulin resistance. Nature 420:333-336 (Pubitemid 35398190)
12. Kim JK, Fillmore JJ, Sunshine MJ, Albrecht B, Higashimori T, Kim DW, Liu ZX, Soos TJ, Cline GW, O'Brien WR, Littman DR, Shulman GI 2004 PKC-θ knockout mice are protected from fat-induced insulin resistance. J Clin Invest 114:823-827 (Pubitemid 39578741)
13. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, Shoelson SE 2005 Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB. Nat Med 11:183-190 (Pubitemid 40321354)
14. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE 2001 Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkß. Science 293:1673-1677 (Pubitemid 32807849)
15. Chang MM, Leeman SE 1970 Isolation of a sialogogic peptide from bovine hypothalamic tissue and its characterization as substance P. J Biol Chem 245:4784-4790
16. Ribeiro-da-Silva A, Hökfelt T 2000 Neuroanatomical localisation of substance P in the CNS and sensory neurons. Neuropeptides 34:256-271
17. Koon HW, Pothoulakis C 2006 Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann NY Acad Sci 1088:23-40 (Pubitemid 47092045)
18. Baroncelli GI, Bertelloni S, Buggiani B, Papini A, Gualtieri M, Saggese G 1989 Evidence of increased levels of substance P in obese children. Funct Neurol 4:183-184 (Pubitemid 19126067)
19. Karagiannides I, Kokkotou E, Tansky M, Tchkonia T, Giorgadze N, O'Brien M, Leeman SE, Kirkland JL, Pothoulakis C 2006 Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proc Natl Acad Sci USA 103:5207-5212
20. Neels JG, Badeanlou L, Hester KD, Samad F 2009 Keratinocyte-derived chemokine in obesity: expression and role in adipose macrophage infiltration and glucose homeostasis. J Biol Chem 284:20692-20698
21. Jacinto E, Lorberg A 2008 TOR regulation of AGC kinases in yeast and mammals. Biochem J 410:19-37 (Pubitemid 351300322)
22. Tanti JF, Jager J 2009 Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Curr Opin Pharmacol 9:753-762
23. Karagiannides I, Torres D, Tseng YH, Bowe C, Carvalho E, Espinoza D, Pothoulakis C, Kokkotou E 2008 Substance P as a novel anti-obesity target. Gastroenterology 134:747-755
24. Karagiannides I, Stavrakis D, Bakirtzi K, Kokkotou E, Pirtskhalava T, Nayeb-Hashemi H, Bowe C, Bugni JM, Nuño M, Lu B, Gerard NP, Leeman SE, Kirkland JL, Pothoulakis C 2011 Substance P (SP)-neurokinin-1 receptor (NK-1R) alters adipose tissue responses to high-fat diet and insulin action. Endocrinology 152:2197-2205
25. Patacchini R, Lecci A, Holzer P, Maggi CA 2004 Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature. Trends Pharmacol Sci 25:1-3 (Pubitemid 38076948)
26. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI 1998 Primary afferent tachykinins are required to experience moderate to intense pain. Nature 392:390-394 (Pubitemid 28168735)
27. Kirkland JL, Hollenberg CH, Gillon WS 1990 Age, anatomic site, and the replication and differentiation of adipocyte precursors. Am J Physiol 258:C206-C210 (Pubitemid 20094615)
28. Karagiannides I, Thomou T, Tchkonia T, Pirtskhalava T, Kypreos KE, Cartwright A, Dalagiorgou G, Lash TL, Farmer SR, Timchenko NA, Kirkland JL 2006 Increased CUG triplet repeat-binding protein-1 predisposes to impaired adipogenesis with aging. J Biol Chem 281:23025-23033
29. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV 1996 Leptin: the tale of an obesity gene. Diabetes 45:1455-1462 (Pubitemid 26357535)
30. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA 2001 Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935 (Pubitemid 32472900)
31. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83 (Pubitemid 29299050)
32. Yatagai T, Nagasaka S, Taniguchi A, Fukushima M, Nakamura T, Kuroe A, Nakai Y, Ishibashi S 2003 Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52:1274-1278 (Pubitemid 37351094)
33. Christiansen T, Richelsen B, Bruun JM 2004 Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes (Lond) 29:146-150 (Pubitemid 40065478)
34. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415
35. 307. J Biol Chem 275:9047-9054
36. Tchkonia T, Giorgadze N, Pirtskhalava T, Tchoukalova Y, Karagiannides I, Forse RA, DePonte M, Stevenson M, Guo W, Han J, Waloga G, Lash TL, Jensen MD, Kirkland JL 2002 Fat depot origin affects adipogenesis in primary cultured and cloned human preadipocytes. Am J Physiol Regul Integr Comp Physiol 282:R1286-R1296 (Pubitemid 34664512)
37. Tchkonia T, Lenburg M, Thomou T, Giorgadze N, Frampton G, Pirtskhalava T, Cartwright A, Cartwright M, Flanagan J, Karagiannides I, Gerry N, Forse RA, Tchoukalova Y, Jensen MD, Pothoulakis C, Kirkland JL 2007 Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab 292:E298-E307 (Pubitemid 46052953)
38. Cleveland-Donovan K, Maile LA, Tsiaras WG, Tchkonia T, Kirkland JL, Boney CM 2010 IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects. Endocrinology 151:3752-3763
39. Gross K, Karagiannides I, Thomou T, Koon HW, Bowe C, Kim H, Giorgadze N, Tchkonia T, Pirtskhalava T, Kirkland JL, Pothoulakis C2009 Substance P promotes expansion of human mesenteric preadipocytes through proliferative and antiapoptotic pathways. Am J Physiol Gastrointest Liver Physiol 296:G1012-G1019
40. Morino K, Petersen KF, Shulman GI 2006 Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes 55(Suppl 2):S9-S15 (Pubitemid 44927027)
41. Azzolina A, Guarneri P, Lampiasi N 2002 Involvement of P38 and JNK MAPKs pathways in substance P-induced production of TNF-α by peritoneal mast cells. Cytokine 18:72-80 (Pubitemid 34754096)
42. Ramnath RD, Sun J, Adhikari S, Bhatia M 2007 Effect of mitogen-activated protein kinases on chemokine synthesis induced by substance P in mouse pancreatic acinar cells. J Cell Mol Med 11:1326-1341
43. Morteau O, Lu B, Gerard C, Gerard NP 2001 Hemokinin 1 is a full agonist at the substance P receptor. Nat Immunol 2:1088 (Pubitemid 33130136)
44. Garza A, Tweardy DJ, Weinstock J, Viswanathan B, Robinson P 2010 Substance P signaling contributes to granuloma formation in Taenia crassiceps infection, a murine model of cysticercosis. J Biomed Biotechnol 2010:597086
45. Helyes Z, Elekes K, Sándor K, Szitter I, Kereskai L, Pintér E, Kemény A, Szolcsányi J, McLaughlin L, Vasiliou S, Kipar A, Zimmer A, Hunt SP, Stewart JP, Quinn JP 2010 Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation. Neuropeptides 44:399-406
46. Ma X, Torbenson M, Hamad AR, Soloski MJ, Li Z 2008 High-fat diet modulates non-CD1d-restricted natural killer T cells and regulatory T cells in mouse colon and exacerbates experimental colitis. Clin Exp Immunol 151:130-138 (Pubitemid 350230983)
47. Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA 2009 Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 29:1458-1464
48. Gross KJ, Pothoulakis C 2007 Role of neuropeptides in inflammatory bowel disease. Inflamm Bowel Dis 13:918-932 (Pubitemid 47203871)
49. Herpfer I, Lieb K 2005 Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs 19:275-293 (Pubitemid 40593599)